Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?
Melanoma cells employ several survival strategies, including induction of the unfolded protein response, which mediates resistance to endoplasmic reticulum (ER) stress-induced apoptosis. Activation of oncogenes specifically suppresses ER stress-induced apoptosis, while upregulation of ER chaperone proteins and antiapoptotic BCL-2 family members increases the protein folding capacity of the cell and the threshold for the induction of ER stress-induced apoptosis, respectively. Modulation of unfolded protein response signaling, inhibition of the protein folding machinery and/or active induction of ER stress may thus represent potential strategies for the therapeutic management of melanoma. To this aim, the present article focuses on the current understanding of how melanoma cells avoid or overcome ER stress-induced apoptosis, as well as therapeutic strategies through which to harness ER stress for therapeutic benefit.
['Hill|David S|DS|', 'Lovat|Penny E|PE|', 'Haass|Nikolas K|NK|']
endoplasmic reticulum stress melanoma unfolded protein response ER apoptosis Grp78/BiP HSP90 IRE1α PDI PERK UPR targeted therapy